Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -292,876 | -350,544 | -285,620 | -268,113 | -226,505 |
| Depreciation Amortization | 4,926 | 1,238 | 2,175 | 3,037 | 4,485 |
| Accounts receivable | -7,698 | 607 | -3,750 | 1,000 | -943 |
| Accounts payable and accrued liabilities | -2,652 | 1,881 | -5,242 | 4,308 | -4,061 |
| Other Working Capital | -61,455 | -51,635 | -1,181 | 38,198 | -7,727 |
| Other Operating Activity | 121,832 | 72,395 | 68,493 | 25,115 | 27,499 |
| Operating Cash Flow | $-237,923 | $-326,058 | $-225,125 | $-196,455 | $-207,252 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -368,747 | -259,083 | -575,624 | -252,323 | -266,068 |
| PPE Investments | -1,544 | -2,559 | -1,236 | -1,864 | -4,746 |
| Sale Of Investment | 297,289 | 435,723 | 353,088 | 394,730 | 324,100 |
| Purchase Sale Intangibles | N/A | N/A | -5,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -5,000 | 0 | -341 |
| Investing Cash Flow | $-73,002 | $174,081 | $-228,772 | $140,543 | $52,945 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 121,703 | 95,000 | 47,444 | 50,000 | N/A |
| Common Stock Issued | 268,837 | 15,389 | 399,536 | 1,441 | 284,164 |
| Other Financing Activity | -976 | -140 | 0 | 6,300 | -882 |
| Financing Cash Flow | $389,564 | $110,249 | $446,980 | $57,741 | $283,282 |
| Exchange Rate Effect | -2 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 140,013 | 181,741 | 188,658 | 186,829 | 57,514 |
| End Cash Position | 218,650 | 140,013 | 181,741 | 188,658 | 186,488 |
| Net Cash Flow | $78,637 | $-41,728 | $-6,917 | $1,829 | $128,974 |
| Free Cash Flow | |||||
| Operating Cash Flow | -237,923 | -326,058 | -225,125 | -196,455 | -207,252 |
| Capital Expenditure | -1,544 | -2,559 | -1,236 | -1,864 | -4,746 |
| Free Cash Flow | -239,467 | -328,617 | -226,361 | -198,319 | -211,998 |